X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.ema.europa.eu/en/documents/overview/atectura-breezhaler-epar-medicine-overview_en.pdf
https://health.economictimes.indiatimes.com/news/pharma/glenmark-launches-fdc-asthma-medication-in-india/92247274
https://www.ema.europa.eu/en/documents/assessment-report/bemrist-breezhaler-epar-public-assessment-report_en.pdf
http://www.pmlive.com/pharma_news/novartis_asthma_triple_heads_chmps_latest_meeting_1339751
https://www.prnewswire.com/news-releases/sosei-heptares-notes-that-enerzair-breezhaler-qvm149-has-been-recommended-for-approval-in-the-european-union-for-treating-uncontrolled-asthma-301050859.html
https://www.ema.europa.eu/en/news/first-triple-combination-therapy-asthma-optional-electronic-sensor
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-23-26-march-2020
https://endpts.com/with-ema-review-in-progress-novartis-unveils-more-positive-data-on-asthma-therapy/
https://www.prnewswire.com/news-releases/sosei-heptares-announces-that-the-copd-treatment-ultibro-breezhaler-has-been-included-in-the-national-reimbursement-drug-list-in-china-300966545.html
http://www.pharmatimes.com/news/novartishits_targets_in_late-stage_qmf149_asthma_trial_1289540
https://www.fiercepharma.com/marketing/novartis-rolls-out-heart-helping-data-for-ultibro-copd-edge
http://www.pharmatimes.com/news/novartis_ultibro_breezhaler_reduces_lung_hyperinflation_in_copd_patients_1223705
http://www.pharmatimes.com/news/five_firms_named_in_breaches_of_abpi_code_1205421
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/delhi-high-court-quashes-ciplas-appeal-says-it-cant-market-generics-of-novartis-onbrez/articleshow/57556608.cms
http://www.prnewswire.com/news-releases/novartis-out-licenses-three-copd-products-in-the-us-300382452.html
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-to-market-novartis-inhaler-under-loftair-brand-name/articleshow/51780460.cms
http://www.reuters.com/article/us-pharmaceuticals-data-idUSKCN0V41LY
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/onbrez-case-delhi-high-court-reserves-decision-on-novartis-cipla-patent-dispute/articleshow/48979313.cms
http://www.pharmatimes.com/Article/15-05-21/Novartis_COPD_therapies_hit_Phase_III_targets.aspx
http://www.cipla.com/getattachment/44e3b55c-cb66-413c-8f4f-22a00fe8d078/Cipla-patent.pdf.aspx?ext=.pdf
Market Place
Share 
